Abraham, Edward; Guidotti, Guido; Rapaport, Eliezer; Bower, David; Brown, Jack; Griffin, Robert J.; Waitzkin, Ellen D.; Qamar, Kenon; Thompson, Mark A.; Ethirajan, Sukumar; Robinson, Kent
We previously published an article in Science discussing the role of ATP in cystic fibrosis (CF). (1) In this manuscript, we update the findings published in that article and add new evidence that the elevated levels of ATP in CF patients may have a protective benefit CF patients infected by SARS-CoV-2 and suffereing from COVID-19. By extension, we suggest a therapeutic regimen
that may benefit COVID-19 in the general populaton.
